UNSPSC 51282507: Cefroxadine

This classification denotes a cephalosporin antibiotic with the molecular formula C16H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B908C4MV2R, chemically known as 7-(d-2-amino-2-(1,4-cyclohexadienyl)acetamide)-3-methoxy-3-cephem-4-carboxylic acid but generally known as cefroxadine, which bears US NIH Compound Identifier 40117. European Medicines Agency schedules Cefroxadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07419MIG.

UNSPSC 51282507 Cefroxadine is a Commodity code that nominally covers a specific antibiotic product, but recent state and local procurement activity under this code shows little connection to cefroxadine itself. Instead, the tagged opportunities reflect broader pharmaceutical procurement — including antibiotic tablets (doxycycline hyclate and ciprofloxacin hydrochloride), naloxone, and drug deactivation systems — suggesting the code may be used as a catchall or misapplied classifier for various pharmaceutical inventory and emergency-response products. State and local health departments and county public-health agencies are the primary issuing bodies under this code. The work typically involves pharmaceutical warehouse supply contracts, often structured as piggyback arrangements through cooperative purchasing consortia such as MMCAP Infuse, with quarterly or annual deliveries to health facilities and fixed-term agreements (12 months with renewal options or multi-year initial terms).

Recent activity spans Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC (Invitation for Bid, closed August 28, 2026) supplying doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets over 12 months with renewal options. Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually via competitive IFB (posted June 30, 2026, due July 26, 2026) with quarterly deliveries to the Seminole County Community Health Building in Sanford. Both procurements reflect health-department and emergency-response purchasing patterns rather than narrowly defined cefroxadine procurement, indicating the code's practical application diverges substantially from its nominal scope.